title: [Neuroprotective agents in stroke: national opinion].
abstract: The Brazilian Stroke Society constituted a committee composed by specialists from different areas of Brazil that emitted a viewpoint called "National Opinion", written similar to the consensus pattern. The study purpose is to guide and offer subsidies for diagnosis and therapeutical plans for different situations in cerebrovascular diseases. The current article analyses "neuroprotective agents in stroke", discussing the level of evidence for the use of potential neuroprotective drugs and ongoing clinical trials.
authors.forename: Gabriel R de
authors.initials: GR
authors.lastname: Freitas
authors.forename: Jorge El Kadum
authors.initials: Jel K
authors.lastname: Noujaim
authors.forename: Sérgio R
authors.initials: SR
authors.lastname: Haussen
authors.forename: Fábio I
authors.initials: FI
authors.lastname: Yamamoto
authors.forename: Edson M
authors.initials: EM
authors.lastname: Novak
authors.forename: Rubens J
authors.initials: RJ
authors.lastname: Gagliardi
mesh_terms: D001938:Brazil; D017326:Clinical Trials, Phase III as Topic / Q000592:standards; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D012955:Societies, Medical; D020521:Stroke / Q000188:drug therapy*
chemical_list: D018696:Neuroprotective Agents